AN INSIGHT ABOUT THE DRUG RELEASE MECHANISMS FROM DIFFERENT DOSAGE FORMS

http://dx.doi.org/10.31703/gdddr.2016(I-I).01      10.31703/gdddr.2016(I-I).01      Published : Dec 2016
Authored by : HafsaShahid , AyeshaAhmed , AmmarahAshraf , NidaRashid , MubashirRehman

01 Pages : 1-8

References

  • Balant L. P. (1993). Regulatory aspects of modified release dosage forms: clinical studies. Bollettinochimicofarmaceutico, 132(5), 143- 149.
  • Garbacz, G., & Klein, S. (2012). Dissolution testing of oral modified-release dosage forms. TheJournal of pharmacy and pharmacology, 64(7), 944- 968.
  • Gupta, B. P., Thakur, N., Jain, N. P., Banweer, J., & Jain, S. (2010). Osmotically controlled drug delivery system with associated drugs. Journal of pharmacy & pharmaceutical sciences: a publication of the Canadian Society for Pharmaceutical Sciences, Societecanadienne des sciences pharmaceutiques, 13(4), 571-588.
  • Hattori, Y., Haruna, Y., & Otsuka, M. (2013). Dissolution process analysis using model-free Noyes-Whitney integral equation. Colloids and surfaces. B, Biointerfaces, 102, 227-231.
  • Keraliya, R. A., Patel, C., Patel, P., Keraliya, V., Soni, T. G., Patel, R. C., & Patel, M. M. (2012). Osmotic drug delivery system as a part of modified release dosage form. ISRN pharmaceutics, 2012, 528079.
  • Mehuys, E., &Vervaet, C. (2010). Systèmesd'administration par voieorale à libérationcontrôlée [Oral controlled release dosage forms]. Journal de pharmacie de Belgique, (2), 34-38.
  • Newman S. P. (2016). Drug delivery to the lungs: challenges and opportunities. Therapeutic delivery, 8(8), 647-661.
  • Şenel, S., Rathbone, M. J., Cansız, M., &Pather, I. (2012). Recent developments in buccal and sublingual delivery systems. Expert opinion on drug delivery, 9(6), 615-628.
  • Siepmann, J., &Siepmann, F. (2012). Modeling of diffusion-controlled drug delivery. Journal of controlled release: official journal of the Controlled Release Society, 161(2), 351-362.
  • Simon, L., Bolisetty, P., &Erazo, M. N. (2011). Dynamics of dissolution and diffusion- controlled drug release systems. Current drug delivery, 8(2), 144-151.
  • Singh Malik, D., Mital, N., & Kaur, G. (2016). Topical drug delivery systems: a patent review. Expert opinion on therapeutic patents, 26(2), 213-228.
  • Verma, R. K., Mishra, B., & Garg, S. (2000). Osmotically controlled oral drug delivery. Drug development and industrial pharmacy, 26(7), 695-708.
  • Vilar, G., Tulla-Puche, J., &Albericio, F. (2012). Polymers and drug delivery systems. Current drug delivery, 9(4), 367-394.

Cite this article

    APA : Shahid, H., Ahmed, A., & Ashraf, A. (2016). An Insight About the Drug Release Mechanisms from Different Dosage Forms. Global Drug Design & Development Review, I(I), 1-8. https://doi.org/10.31703/gdddr.2016(I-I).01
    CHICAGO : Shahid, Hafsa, Ayesha Ahmed, and Ammarah Ashraf. 2016. "An Insight About the Drug Release Mechanisms from Different Dosage Forms." Global Drug Design & Development Review, I (I): 1-8 doi: 10.31703/gdddr.2016(I-I).01
    HARVARD : SHAHID, H., AHMED, A. & ASHRAF, A. 2016. An Insight About the Drug Release Mechanisms from Different Dosage Forms. Global Drug Design & Development Review, I, 1-8.
    MHRA : Shahid, Hafsa, Ayesha Ahmed, and Ammarah Ashraf. 2016. "An Insight About the Drug Release Mechanisms from Different Dosage Forms." Global Drug Design & Development Review, I: 1-8
    MLA : Shahid, Hafsa, Ayesha Ahmed, and Ammarah Ashraf. "An Insight About the Drug Release Mechanisms from Different Dosage Forms." Global Drug Design & Development Review, I.I (2016): 1-8 Print.
    OXFORD : Shahid, Hafsa, Ahmed, Ayesha, and Ashraf, Ammarah (2016), "An Insight About the Drug Release Mechanisms from Different Dosage Forms", Global Drug Design & Development Review, I (I), 1-8
    TURABIAN : Shahid, Hafsa, Ayesha Ahmed, and Ammarah Ashraf. "An Insight About the Drug Release Mechanisms from Different Dosage Forms." Global Drug Design & Development Review I, no. I (2016): 1-8. https://doi.org/10.31703/gdddr.2016(I-I).01